Using advanced genetic testing to diagnose hard-to-find respiratory infections
Part of Infections, Lungs & breathing clinical trials.
This study uses a powerful genetic test (next-generation sequencing) to find the cause of respiratory infections when standard tests fail. It may help identify hard-to-detect viruses, bacteria, or fungi in your lung or airway samples.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You agree to be in the study by signing a consent form.
- Your doctor suspects a respiratory infection, but standard tests haven't found a clear cause.
- Your condition has lasted a long time and hasn't improved with usual treatments.
- You have enough lung or airway samples (like sputum or a swab) for testing.
- Your medical records are complete.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether a special genetic test (tNGS) can predict which antibiotics will work for bacteria causing lung infections. It may help doctors choose the right treatment faster.
This study uses advanced genetic testing to monitor antibiotic-resistant bacteria in people with pneumonia. It aims to understand how resistance develops and improve treatment choices.
This trial tests a new way to predict how well patients with a ventilator-associated lung infection will respond to treatment. It uses two bronchoscopy samples to track bacteria levels and guide better care.
This study tests new diagnostic tools to help quickly identify what's causing your respiratory infection. You'll provide samples (like nasal swabs) to help researchers understand how these new tests work in real patients.
This study is for people with HIV/AIDS who develop severe pneumonia or septic shock. It uses a special genetic test (metagenomic next-generation sequencing) to find the exact germ causing the infection so doctors can choose the right antibiotic.
This study compares a newer, faster lab test (BioFire FilmArray) to standard testing for identifying the germs causing lung infections in hospitalized patients. The goal is to see if the faster test helps doctors choose better antibiotics more quickly.
Hear when a new Lung Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.